Product Data Sheet

ODN 2336

Catalog No. A35339

main product photo
ODN 2336 is a potent TLR9 agonist classified as an A-Class CpG oligodeoxynucleotide (ODN). It effectively stimulates the production of interferon-alpha (IFN-α) and upregulates the expression of IP-10 and IL-18 mRNA. ODN 2336 serves as a valuable adjuvant in vaccine development and research, enhancing immune responses and providing insights into nucleic acid-based immunotherapy.
Chemical Information
Catalog NumA35339
M. Wt6761.70
Formula
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.332956-64-6
Synonyms
SMILES[DNA, d(G-sp-G-sp-G-G-A-C-G-A-C-G-T-C-G-T-G-G-sp-G-sp-G-sp-G-sp-G-sp-G)]
Biological Activity
DescriptionODN 2336 is a potent TLR9 agonist classified as an A-Class CpG oligodeoxynucleotide (ODN). It effectively stimulates the production of interferon-alpha (IFN-α) and upregulates the expression of IP-10 and IL-18 mRNA. ODN 2336 serves as a valuable adjuvant in vaccine development and research, enhancing immune responses and providing insights into nucleic acid-based immunotherapy.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.